C07C 217/48
The carbon skeleton being unsaturated and containing rings
Official title: the carbon skeleton being unsaturated and containing rings
C07C217/48 (The carbon skeleton being unsaturated and containing rings) appears on 171 US grants and 152 published applications in this corpus.
Search patents in C07C- Granted patents
- 171
- Published applications
- 152
- Assignees
- 105
- Inventors
- 457
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 4 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 4 | 0 |
| 1992 | 6 | 0 |
| 1993 | 7 | 0 |
| 1994 | 5 | 0 |
| 1995 | 3 | 0 |
| 1996 | 4 | 0 |
| 1997 | 6 | 0 |
| 1998 | 2 | 0 |
| 1999 | 4 | 0 |
| 2000 | 3 | 0 |
| 2001 | 8 | 0 |
| 2002 | 5 | 6 |
| 2003 | 1 | 4 |
| 2004 | 5 | 7 |
| 2005 | 2 | 7 |
| 2006 | 1 | 11 |
| 2007 | 3 | 7 |
| 2008 | 11 | 5 |
| 2009 | 6 | 13 |
| 2010 | 3 | 10 |
| 2011 | 5 | 8 |
| 2012 | 7 | 6 |
| 2013 | 13 | 8 |
| 2014 | 4 | 7 |
| 2015 | 4 | 9 |
| 2016 | 8 | 9 |
| 2017 | 5 | 5 |
| 2018 | 6 | 6 |
| 2019 | 3 | 1 |
| 2020 | 1 | 4 |
| 2021 | 5 | 7 |
| 2022 | 4 | 1 |
| 2023 | 4 | 4 |
| 2024 | 1 | 3 |
| 2025 | 1 | 2 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- 5-methoxymethyl and 5-hydroxymethyl phenethylamines28 Jul 2026US 12,692,221 B22A Biosciences, Inc.
- Oral complement factor D inhibitors24 Feb 2026US 12,558,341 B2BioCryst Pharmaceuticals, Inc.
- Use of small molecule inhibitors to KLF10 for modulation of T regulatory cells and cancer immunotherapy30 Sep 2025US 12,428,410 B2Beth Israel Deaconess Medical Center, Inc.
- Functionalized N,N-dialkylamino phenyl ethers and their method of use16 Jan 2024US 11,873,267 B2Temple University of the Commonwealth System of Higher Education
- Modulators of Mas-related G-protein receptor X4 and related products and methods12 Dec 2023US 11,840,521 B2Escient Pharmaceuticals, Inc.
- Oral complement factor d inhibitors18 Jun 2026US 2026/0165999 A1BioCryst Pharmaceuticals, Inc.
- Modulators of mas-related g-protein receptor x4 and related products and methods23 Apr 2026US 2026/0108482 A1Escient Pharmaceuticals, Inc.
- 5-methoxymethyl and 5-hydroxymethyl phenethylamines20 Nov 2025US 2025/0353808 A12A Biosciences, Inc.
- Oral complement factor d inhibitors12 Jun 2025US 2025/0186391 A1BioCryst Pharmaceuticals, Inc.
- Arginine methyltransferase inhibitor and use thereof19 Sep 2024US 2024/0307409 A1Cytosinlab Therapeutics Co. Ltd.
Most cited
By later US patents
- 2-amino-1,3-propanediol compound and immunosuppressant76US 5,604,229 ATaito Co., Ltd. · 1997
- (+)-1-[(3 ,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-N-propylamine, process for preparing it and its therapeutical use65US 5,245,080 AJouveinal S.A. · 1993
- Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases45US 6,071,970 ANPS Pharmaceuticals, Inc. · 2000
- Cocrystallization41US 7,452,555 B2S.S.C.I., Inc. · 2008
- Diphenylheteroalkyl derivatives, the preparation thereof and drugs and cosmetics prepared therefrom32US 5,087,743 ABASF SE · 1992